Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000438
Status:
COMPLETED
Last Update Posted:
2010-05-14
First Post:
1999-11-02
Brief Title:
Naltrexone Treatment for Alcoholism
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Study Overview
Official Title:
Naltrexone Treatment for Alcoholism Predicting Outcome
Status:
COMPLETED
Status Verified Date:
2010-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effectiveness of the medication naltrexone Revia for treating alcoholism Individuals will be inpatients for a 2 week period and provide assessments of their alcohol withdrawal symptoms craving and mood Following hospital discharge individuals will be assigned randomly to receive naltrexone daily naltrexone twice a day or a placebo This part of the study will last 12 weeks with regular measurements of drinking level craving and mood Assessments will be conducted 6 and 12 months after the beginning of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01AA011855 | NIH | None | httpsreporternihgovquickSearchR01AA011855 |